These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19051623)

  • 1. [When and how to withdraw glucocorticoid therapy in elderly?].
    Ardigo S; Genevay S; Vischer U
    Rev Med Suisse; 2008 Nov; 4(178):2374-8, 2380-1. PubMed ID: 19051623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenal insufficiency after glucocorticoid withdrawal in children with rheumatic diseases.
    Huber BM; Bolt IB; Sauvain MJ; Flück CE
    Acta Paediatr; 2010 Dec; 99(12):1889-93. PubMed ID: 20649769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glucocorticoid treatments and adrenal function].
    Guignat L; de Bucy C; Bertherat J
    Rev Prat; 2008 May; 58(9):966-70. PubMed ID: 18672662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal insufficiency secondary to glucocorticoid withdrawal in patients with brain tumor.
    Da Silva AN; Schiff D
    Surg Neurol; 2007 May; 67(5):508-10. PubMed ID: 17445619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Benefits and risks of glucocorticoid therapy for the treatment of rheumatoid arthritis and management of glucocorticoid-induced osteoporosis].
    Suzuki Y; Wakabayashi T; Saito E; Yamada C; Suwa A
    Clin Calcium; 2009 Mar; 19(3):404-15. PubMed ID: 19252251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Iatrogenic adrenal cortex insufficiency following corticosteroid therapy].
    Bürgi H
    Schweiz Rundsch Med Prax; 1988 Feb; 77(5):82-5. PubMed ID: 2831605
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic issues in oral glucocorticoid use.
    Bello CE; Garrett SD
    Lippincotts Prim Care Pract; 1999; 3(3):333-41; quiz 342-4. PubMed ID: 10711134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases.
    Duru N; van der Goes MC; Jacobs JW; Andrews T; Boers M; Buttgereit F; Caeyers N; Cutolo M; Halliday S; Da Silva JA; Kirwan JR; Ray D; Rovensky J; Severijns G; Westhovens R; Bijlsma JW
    Ann Rheum Dis; 2013 Dec; 72(12):1905-13. PubMed ID: 23873876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimum management of glucocorticoid-treated patients.
    Trikudanathan S; McMahon GT
    Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):262-71. PubMed ID: 18349823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of medications and hormones used in pediatric endocrinology: adrenal.
    Frank GR; Speiser PW; Griffin KJ; Stratakis CA
    Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():134-45. PubMed ID: 16456492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenal response to glucocorticoid treatment.
    Vanpee D; Gillet JB
    Lancet; 2000 Apr; 355(9213):1458; author reply 1459. PubMed ID: 10791542
    [No Abstract]   [Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Minimizing side effects of glucocorticoid therapy].
    Kawai S; Mizushima Y
    Nihon Rinsho; 1994 Mar; 52(3):767-72. PubMed ID: 8164380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Secondary adrenal insufficiency after local injections of triamcinolone acetonide].
    Schott S; Schnauder G; Müssig K
    Dtsch Med Wochenschr; 2009 Feb; 134(7):298-301. PubMed ID: 19197811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synthetic glucocorticoid therapy--recent progress].
    Miyachi Y
    Nihon Rinsho; 2000 Nov; 58(11):2353-63. PubMed ID: 11225329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous Cushing's syndrome and glucocorticoid withdrawal.
    Hopkins RL; Leinung MC
    Endocrinol Metab Clin North Am; 2005 Jun; 34(2):371-84, ix. PubMed ID: 15850848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-related patterns of glucocorticoid-induced side effects.
    Huscher D; Thiele K; Gromnica-Ihle E; Hein G; Demary W; Dreher R; Zink A; Buttgereit F
    Ann Rheum Dis; 2009 Jul; 68(7):1119-24. PubMed ID: 18684744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of neonatal hydrocortisone treatment for chronic lung disease on the developing brain and heart.
    Rademaker KJ; de Vries WB
    Semin Fetal Neonatal Med; 2009 Jun; 14(3):171-7. PubMed ID: 19101215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tapered treatment with corticosteroids].
    Zipf A
    Hautarzt; 1993 Mar; 44(3):180. PubMed ID: 8463102
    [No Abstract]   [Full Text] [Related]  

  • 20. Current controversies in critical illness-related corticosteroid insufficiency and glucocorticoid supplementation.
    Gross AK; Winstead PS
    Orthopedics; 2009 Sep; 32(9):. PubMed ID: 19751024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.